Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Advances in Therapy
|
May 6, 2024
Adherence and Persistence Among Risdiplam-Treated Individuals with Spinal Muscular Atrophy: A Retrospective Claims Analysis
Elmor D Pineda, Tu My To, Travis L Dickendesher, et al.
Pharmacoeconomics
|
February 1, 2024
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA
Shih-Wen Lin, Sheila Shapouri, Hélène Parisé, et al.
Oncology (Williston Park, N.Y.)
|
January 28, 2022
Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab
Esther Drill, Annie Qiu, Sheila Shapouri, et al.
Journal of Medical Economics
|
May 7, 2024
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar, Javier Sanchez Alvarez, Hélène Parisé, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2021
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
Anuja Chatterjee, Sheila Shapouri, Beenish S Manzoor, et al.
Cost Effectiveness and Resource Allocation : C/E
|
August 23, 2023
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
Abigail G Riley, Christina M Mulé, Debra Lerner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 18, 2025
Author Reply
Tara A Lavelle, Sheila Shapouri, Abigail Riley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 12, 2025
Mental Health, Quality of Life, and Work Functioning of Parents of Children Who Have Died of Spinal Muscular Atrophy
Tara A Lavelle, Abigail Riley, Stacey Kowal, et al.
Pharmacoeconomics
|
May 9, 2020
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States
Sang Kyu Cho, Beenish S Manzoor, Kavita R Sail, et al.
Journal of Pain and Symptom Management
|
September 24, 2025
Bereavement Experiences Among Parents of Children With Spinal Muscular Atrophy Type 1
Christina M Mulé, Abigail Riley, Debra Lerner, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Advances in Therapy
|
May 6, 2024
Adherence and Persistence Among Risdiplam-Treated Individuals with Spinal Muscular Atrophy: A Retrospective Claims Analysis
Elmor D Pineda, Tu My To, Travis L Dickendesher, et al.
Pharmacoeconomics
|
February 1, 2024
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA
Shih-Wen Lin, Sheila Shapouri, Hélène Parisé, et al.
Oncology (Williston Park, N.Y.)
|
January 28, 2022
Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab
Esther Drill, Annie Qiu, Sheila Shapouri, et al.
Journal of Medical Economics
|
May 7, 2024
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar, Javier Sanchez Alvarez, Hélène Parisé, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2021
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
Anuja Chatterjee, Sheila Shapouri, Beenish S Manzoor, et al.
Cost Effectiveness and Resource Allocation : C/E
|
August 23, 2023
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
Abigail G Riley, Christina M Mulé, Debra Lerner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 18, 2025
Author Reply
Tara A Lavelle, Sheila Shapouri, Abigail Riley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 12, 2025
Mental Health, Quality of Life, and Work Functioning of Parents of Children Who Have Died of Spinal Muscular Atrophy
Tara A Lavelle, Abigail Riley, Stacey Kowal, et al.
Pharmacoeconomics
|
May 9, 2020
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States
Sang Kyu Cho, Beenish S Manzoor, Kavita R Sail, et al.
Journal of Pain and Symptom Management
|
September 24, 2025
Bereavement Experiences Among Parents of Children With Spinal Muscular Atrophy Type 1
Christina M Mulé, Abigail Riley, Debra Lerner, et al.
Page
of 2